Scynexis (SCYX) Assets Average (2014 - 2026)
Scynexis (SCYX) posted Assets Average of $68.3 million for Q1 2026, up 24.12% on a QoQ basis from $55.0 million in Q4 2025, and down 13.82% year-over-year from $79.3 million in Q1 2025.
Scynexis (SCYX) Assets Average (2014 - 2026) Analysis & Trends
Scynexis' Assets Average history runs 13 years deep, the most recent figure standing at $68.3 million for Q1 2026.
- Quarterly Assets Average fell 13.82% year-over-year to $68.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $68.3 million (down 13.82% YoY) and the FY2025 annual result came in at $74.8 million, down 31.67% from the prior year.
- Assets Average was $68.3 million for Q1 2026 at Scynexis, up from $55.0 million in the prior quarter.
- Across five years, Assets Average topped out at $151.7 million in Q3 2023 and bottomed at $55.0 million in Q4 2025.
- A 5-year average of $100.2 million and a median of $103.4 million in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2024 — Assets Average surged 56.01% — and 2025, when it sank 45.97%.
- Scynexis' Assets Average stood at $100.1 million in 2022, then jumped by 38.41% to $138.5 million in 2023, then tumbled by 31.51% to $94.8 million in 2024, then tumbled by 41.96% to $55.0 million in 2025, then advanced by 24.12% to $68.3 million in 2026.
- Business Quant data shows SCYX's Assets Average at $68.3 million in Q1 2026, $55.0 million in Q4 2025, and $55.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Scynexis | 21.55 Mn | -15.20 Mn | - | 68.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 68.33 Mn |
| Dec 31, 2025 | 55.05 Mn |
| Sep 30, 2025 | 55.88 Mn |
| Jun 30, 2025 | 64.30 Mn |
| Mar 31, 2025 | 79.28 Mn |
| Dec 31, 2024 | 94.84 Mn |
| Sep 30, 2024 | 103.42 Mn |
| Jun 30, 2024 | 113.03 Mn |
| Mar 31, 2024 | 123.33 Mn |
| Dec 31, 2023 | 138.48 Mn |
| Sep 30, 2023 | 151.70 Mn |
| Jun 30, 2023 | 112.58 Mn |
| Mar 31, 2023 | 79.05 Mn |
| Dec 31, 2022 | 100.05 Mn |
| Sep 30, 2022 | 123.95 Mn |
| Jun 30, 2022 | 123.59 Mn |
| Mar 31, 2022 | 115.70 Mn |
| Dec 31, 2021 | 114.86 Mn |
| Sep 30, 2021 | 115.51 Mn |
| Jun 30, 2021 | 110.60 Mn |